Signaling Pathways - MAGL - GPR35 - Thymidylate Synthase - Insulin and Insulin-like Receptors
清除全部
-
B6367 NPPBTarget: Calcium-activated chloride channels (CaCC)|GPR35Summary: 氯离子通道抑制剂 -
B1476 Raltitrexed中文名: 雷替曲塞Target: Thymidylate SynthaseSummary: 胸苷酸合酶抑制剂 -
A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂 -
A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂 -
A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂 -
A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂 -
A4390 Pemetrexed1 Citation中文名: 培美曲塞二钠盐Target: Thymidylate Synthase|DHFR|GARFTSummary: TS、DHFR、GARFT和AICARFT抑制剂 -
A4302 Rosiglitazone maleate中文名: 马来酸罗格列酮Target: Insulin and Insulin-like ReceptorsSummary: PPARγ激动剂，有效的胰岛素敏化剂 -
A4071 Fluorouracil (Adrucil)3 Citation中文名: 氟尿嘧啶Target: Thymidylate SynthaseSummary: 胸苷酸合成酶抑制剂，抗肿瘤药物。 -
N1846 Tanshinone IIA中文名: 丹参酮IIATarget: AP-1|MAGLSummary: 抗氧化和抗炎剂